SCHEDULE 13G

Company

Royalty Pharma plc

Filed

February 16, 2021

Accession Number

0000950142-21-000545

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →